论文部分内容阅读
目的探讨不同剂量米非司酮用于子宫肌瘤治疗的临床效果。方法选取本院2014-01-2015-01接诊的子宫肌瘤患者120例,将其随机分为观察组与对照组,每组各60例,观察组使用小剂量米非司酮进行治疗,对照组使用大剂量进行治疗,治疗时间为3个月,观察两组患者的治疗效果。结果观察组的子宫体积、肌瘤体积有明显缩小,且服药后不良反应较对照组患者少,两组患者对比差异显著,具有统计学意义。结论小剂量米非司酮治疗子宫肌瘤的临床效果极好,且服药后不良反应率较低,安全性较高。
Objective To investigate the clinical effect of different doses of mifepristone for the treatment of uterine fibroids. Methods A total of 120 patients with uterine leiomyoma admitted to our hospital from January 2014 to January 2015 were selected and randomly divided into observation group and control group, 60 cases in each group. The observation group was treated with low dose of mifepristone, Control group using high-dose treatment, the treatment time was 3 months, the two groups were observed treatment. Results The volume of uterus and fibroids in the observation group was significantly reduced, and the adverse reaction was less than that in the control group after taking the drug. The difference between the two groups was significant and statistically significant. Conclusion The low dose of mifepristone treatment of uterine fibroids excellent clinical results, and medication after the adverse reaction rate is low, high safety.